科兴制药涨2.15%，成交额1.22亿元，主力资金净流入456.41万元

Core Viewpoint - The stock price of Kexing Pharmaceutical has shown significant volatility, with a year-to-date increase of 91.68%, but a recent decline in the last five and twenty trading days [2] Group 1: Stock Performance - As of September 12, Kexing Pharmaceutical's stock price rose by 2.15% to 41.75 CNY per share, with a trading volume of 1.22 billion CNY and a market capitalization of 8.402 billion CNY [1] - The stock has experienced a decline of 1.23% over the last five trading days and 6.45% over the last twenty trading days, while it has increased by 2.45% over the last sixty days [2] Group 2: Financial Performance - For the first half of 2025, Kexing Pharmaceutical reported a revenue of 700 million CNY, a year-on-year decrease of 7.82%, while the net profit attributable to shareholders was 80.3445 million CNY, reflecting a year-on-year increase of 576.45% [2] - The company has distributed a total of 51.5446 million CNY in dividends since its A-share listing, with 15.7785 million CNY distributed in the last three years [3] Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders for Kexing Pharmaceutical increased by 16.86% to 9,412, while the average circulating shares per person decreased by 14.43% to 21,211 shares [2] - The top shareholders include E Fund Medical Healthcare Industry Mixed A, which increased its holdings by 1.6955 million shares, and other funds that have also adjusted their positions [3]